- Home
- DEI vs VRNA Comparison
DEI vs VRNA Comparison
Compare DEI & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEI
- VRNA
- Stock Information
- Founded
- DEI 1971
- VRNA 2005
- Country
- DEI United States
- VRNA United Kingdom
- Employees
- DEI N/A
- VRNA N/A
- Industry
- DEI Real Estate Investment Trusts
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- DEI Real Estate
- VRNA Health Care
- Exchange
- DEI Nasdaq
- VRNA Nasdaq
- Market Cap
- DEI 3.2B
- VRNA 3.4B
- IPO Year
- DEI 2006
- VRNA 2017
- Fundamental
- Price
- DEI $19.00
- VRNA $46.72
- Analyst Decision
- DEI Hold
- VRNA Strong Buy
- Analyst Count
- DEI 7
- VRNA 6
- Target Price
- DEI $17.43
- VRNA $43.83
- AVG Volume (30 Days)
- DEI 1.3M
- VRNA 813.9K
- Earning Date
- DEI 02-04-2025
- VRNA 11-04-2024
- Dividend Yield
- DEI 4.00%
- VRNA N/A
- EPS Growth
- DEI N/A
- VRNA N/A
- EPS
- DEI N/A
- VRNA N/A
- Revenue
- DEI $965,443,000.00
- VRNA $5,624,000.00
- Revenue This Year
- DEI N/A
- VRNA N/A
- Revenue Next Year
- DEI N/A
- VRNA $644.06
- P/E Ratio
- DEI N/A
- VRNA N/A
- Revenue Growth
- DEI N/A
- VRNA 1127.95
- 52 Week Low
- DEI $12.36
- VRNA $11.39
- 52 Week High
- DEI $20.50
- VRNA $46.97
- Technical
- Relative Strength Index (RSI)
- DEI 49.85
- VRNA 71.78
- Support Level
- DEI $17.78
- VRNA $39.67
- Resistance Level
- DEI $20.50
- VRNA $45.98
- Average True Range (ATR)
- DEI 0.65
- VRNA 1.99
- MACD
- DEI -0.15
- VRNA 0.45
- Stochastic Oscillator
- DEI 44.85
- VRNA 96.95
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.